BiotechTube

esomeprazole magnesium (oral medication)

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Erosive Esophagitis

Conditions

Erosive Esophagitis, Reflux Esophagitis, Gastroesophageal Reflux Disease

Trial Timeline

Jun 1, 2004 → Aug 1, 2005

NCT ID
NCT00206180

About esomeprazole magnesium (oral medication)

esomeprazole magnesium (oral medication) is a approved stage product being developed by AstraZeneca for Erosive Esophagitis. The current trial status is completed. This product is registered under clinical trial identifier NCT00206180. Target conditions include Erosive Esophagitis, Reflux Esophagitis, Gastroesophageal Reflux Disease.

What happened to similar drugs?

5 of 12 similar drugs in Erosive Esophagitis were approved

Approved (5) Terminated (0) Active (7)
✅Teprenone capsule and placebo of sucralfate + Sucralfate and placebo of teprenoneEisaiApproved
✅Esomeprazole + LansoprazoleAstraZenecaApproved
✅Esomeprazole + LansoprazoleAstraZenecaApproved
✅Esomeprazole + EsomeprazoleAstraZenecaApproved
✅Omeprazole/sodium bicarbonateBausch HealthApproved
🔄E3810 + E3810 + PlaceboEisaiPhase 3
🔄RABEPRAZOLE SODIUM + RABEPRAZOLE SODIUMEisaiPhase 3

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00206180ApprovedCompleted

Competing Products

20 competing products in Erosive Esophagitis

See all competitors
ProductCompanyStageHype Score
YH1885L(Revaprazan) + Esomeprazole 20mg + placeboYuhanPhase 2
35
E3810 + E3810 + PlaceboEisaiPhase 3
40
RABEPRAZOLE SODIUM + RABEPRAZOLE SODIUMEisaiPhase 3
40
Teprenone capsule and placebo of sucralfate + Sucralfate and placebo of teprenoneEisaiApproved
43
ABT-981 + Placebo for ABT-981AbbViePhase 2
35
OmeprazoleAstraZenecaPhase 3
40
Esomeprazole + LansoprazoleAstraZenecaApproved
43
Nexium 20mg + Nexium 10mgAstraZenecaPhase 3
47
OmeprazoleAstraZenecaPhase 3
40
AZD0865AstraZenecaPhase 2
35
Esomeprazole + LansoprazoleAstraZenecaApproved
43
Esomeprazole + EsomeprazoleAstraZenecaApproved
43
AZD0865AstraZenecaPhase 2
35
Alendronate Effervescent Oral TabletAmgenPhase 2
35
Omeprazole/sodium bicarbonateBausch HealthApproved
37
VonoprazanPhathom PharmaceuticalsPhase 1
23
Vonoprazan + LansoprazolePhathom PharmaceuticalsPhase 3
34
Vonoprazan + PlaceboPhathom PharmaceuticalsPhase 2
29
VonoprazanPhathom PharmaceuticalsPre-clinical
27
Vonoprazan + PlaceboPhathom PharmaceuticalsPhase 3
34